Clinical Trial Reimbursement in the U.S.: FAQs for MedTech Companies
Published on: 19/03/2025
A clear FAQ guide on how MedTech startups can secure Medicare reimbursement for clinical trials—and when it’s worth it.
Evidence PlanningFeatured
A clear FAQ guide on how MedTech startups can secure Medicare reimbursement for clinical trials—and when it’s worth it.
Learn how payer claims data strengthens medtech value stories without long clinical trials.
Understand how real-world data strengthens your U.S. reimbursement case beyond traditional trials.
Why comparing your AI MedTech solution to the status quo isn’t enough for payer approval.
FDA approval ensures safety and effectiveness—but CMS needs proof of clinical value. Here’s how to align your strategy with both mandates.